(firstQuint)Observational Study of Oralair in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis.

 The purpose of this study is to further describe the safety and tolerability of ORALAIR tablets in children 5 to 9 years of age with grass-pollen-induced allergic rhinitis with or without conjunctivitis.

 Patients are followed for safety and tolerability during the first 30 treatment days.

.

 Observational Study of Oralair in Children 5-9 Years With Grass-pollen-induced Allergic Rhinitis With/Without Conjunctivitis@highlight

Safety and tolerability of ORALAIR in children 5 to 9 years of age during the first 30 days of treatment.

